---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-066621"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:50:34.392500+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 2024 revenue $9.2M (+104% YoY); net income $1.6M

## Summary
- Revenue $9.2M vs $4.5M in Q2 2023, up 104%; 23 systems shipped (including 3 to Asia) vs 13 last year.
- Net income $1.6M ($0.10 diluted EPS) vs net loss of $0.4M ($0.02 loss per share) in Q2 2023.
- Adjusted EBITDA $2.1M vs negative $1.0M in prior-year quarter.
- Signed 15 Fair Deal Agreements for SRT-100 Vision units since March 2024; recurring revenue expected in 2025.
- Cash and equivalents $19.0M, no debt; accounts receivable $18.3M vs $10.6M at Dec 31, 2023.

## SEC filing metadata
- accession: 0001213900-24-066621
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/0001213900-24-066621-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390024066621/ea0210736-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-066621
- JSON: https://secwatch.observer/filing/0001213900-24-066621.json
- Plain text: https://secwatch.observer/filing/0001213900-24-066621.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.